Development of a PET radiopharmaceutical for the nuclear imaging of Parkinson’s disease (Q3325996)

From EU Knowledge Graph
Revision as of 22:46, 26 October 2021 by DG Regio (talk | contribs) (‎Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string)
Jump to navigation Jump to search
Project Q3325996 in Germany
Language Label Description Also known as
English
Development of a PET radiopharmaceutical for the nuclear imaging of Parkinson’s disease
Project Q3325996 in Germany

    Statements

    0 references
    0 references
    70,535.36 Euro
    0 references
    88,169.2 Euro
    0 references
    80.0 percent
    0 references
    2 October 2016
    0 references
    31 October 2019
    0 references
    Technische UniversitätDresden
    0 references
    Q3394796 (Deleted Item)
    0 references
    0 references

    51°2'57.59"N, 13°44'17.30"E
    0 references
    Entwicklung eines PET-Radiopharmakons für die nuklearmedizinische Bildgebung der Parkinson-Krankheit (German)
    0 references
    Development of a PET radiopharmaceutical for the nuclear imaging of Parkinson’s disease (English)
    25 October 2021
    0 references
    Dresden, Stadt
    0 references

    Identifiers

    672 / 101002267521
    0 references